社区步行能力与老年脓毒症患者院内死亡率的关系:单中心回顾性队列研究
该单中心回顾性队列研究纳入2014至2017年一家医院ICU收治的年龄≥65岁、符合脓毒症-3标准的脓毒症患者335例,用以入ICU前能否独立出门定义Life Space衰弱评分,121例(36%)为Life Space阳性(衰弱)。主要终点为院内死亡率,校正年龄、性别和序贯器官衰竭评估评分后,Life Space阳性患者院内死亡率高于阴性患者(aOR 2.32;95%CI 1.36-3.96;P=0.002),六组敏感性分析结果一致。亚组分析中,有无治疗限制的患者间交互作用显著(aOR 1.02 vs 2.66,交互作用P=0.042)。作者结论认为,Life Space评估的衰弱与更高的院内死亡率独立相关。
要点
- 入ICU前不能独立出门(Life Space阳性)的老年脓毒症患者院内死亡率更高:aOR 2.32(95%CI 1.36-3.96,P=0.002)。
- 335例中121例(36%)被归类为衰弱(Life Space阳性)。
- 校正年龄、性别和序贯器官衰竭评估评分后,Life Space与院内死亡率的关联仍独立存在。
- 六组敏感性分析在校正不同混杂因素后结果一致。
- 有无治疗限制的亚组间交互作用显著:aOR 1.02 vs 2.66,交互作用P=0.042。
适用人群与场景
- 2014至2017年一家医院ICU收治的年龄≥65岁、符合脓毒症-3标准的脓毒症患者。
诊断标准与关键阈值
- 脓毒症诊断采用脓毒症-3标准。
- 衰弱评估基于患者入ICU前能否独立出门,二分类评分称为Life Space,不能独立出门为Life Space阳性(衰弱)。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究;最终分析335例,121例(36%)为Life Space阳性(衰弱)。
- 主要终点院内死亡率:Life Space阳性患者高于阴性患者,校正年龄、性别和序贯器官衰竭评估评分后aOR 2.32(95%CI 1.36-3.96,P=0.002)。
- 六组敏感性分析在校正不同混杂因素后观察到相似结果。
- 亚组分析:有无治疗限制的患者间交互作用显著(aOR 1.02 vs 2.66,交互作用P=0.042)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,Life Space评估的衰弱与老年脓毒症患者更高的院内死亡率独立相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To examine the association of a simple frailty assessment, Life Space (LS), with in-hospital mortality in elderly patients with sepsis.
METHODS: We used data from a single hospital between 2014 and 2017. We included elderly patients (age ≥ 65 years) admitted to the intensive care unit (ICU) with sepsis, as defined by sepsis-3 criteria. Frailty assessment was based on a patient's ability to independently go out of the house before the ICU admission. We termed this dichotomous score as Life Space. The primary outcome was in-hospital mortality. Logistic regression was used to investigate the association of LS with each outcome after adjusting for age, sex, and Sequential Organ Failure Assessment score.
RESULTS: Of the 335 participants included in the final analysis, 121 (36%) were classified as frail. LS-positive patients had a higher in-hospital mortality (adjusted odds ratio (aOR) 2.32; 95% confidence interval (CI) 1.36-3.96; P = 0.002) than did LS-negative patients. We observed similar patterns in six sets of sensitivity analyses after accounting for different confounders. In subgroup analyses, significant interactions were observed in participants with versus those without treatment limitations (aOR 1.02 vs. 2.66, P for interaction = 0.042).
CONCLUSIONS: In this single-center study, frailty assessed by LS was independently associated with a higher in-hospital mortality.
参考来源
- Ueno R, Shiraishi A, Yamamoto R, et al. Relationship between community walking ability and in-hospital mortality in elderly patients with sepsis: a single-center retrospective cohort study. J Intensive Care. 2019. PMID: 31139418. doi:10.1186/s40560-019-0385-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。